The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Hislop Colin since year 2005.
The trader's CIK number is 1314902.
At the time of this reporting, Hislop Colin is the Chief Medical Officer of Versartis, Inc. .
(stock ticker symbol VSAR).
See this page for all insider trading activities at Versartis, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-04-04||VSAR||Versartis, Inc.||Option Ex||35,000||8.17||285,950|
|2015-11-13||ANTH||Anthera Pharmaceuticals Inc||Sale||12,500||5.31||66,337|
|2015-11-13||ANTH||Anthera Pharmaceuticals Inc||Option Ex||12,500||1.61||20,125|
|2015-11-11||ANTH||Anthera Pharmaceuticals Inc||Sale||5,000||5.38||26,900|
|2012-02-23||ANTH||Anthera Pharmaceuticals Inc||Option Ex||40,000||.26||10,400|
|2012-02-03||ANTH||Anthera Pharmaceuticals Inc||Sale||30,000||8.20||245,999|
|2011-11-08||ANTH||Anthera Pharmaceuticals Inc||Option Ex||15,000||.26||3,900|
|2011-11-08||ANTH||Anthera Pharmaceuticals Inc||Sale||15,000||6.74||101,160|
|2011-07-12||ANTH||Anthera Pharmaceuticals Inc||Option Ex||15,000||.26||3,900|
|2011-06-29||ANTH||Anthera Pharmaceuticals Inc||Option Ex||10,000||.26||2,600|
|2010-09-21||ANTH||Anthera Pharmaceuticals Inc||Option Ex||14,683||.26||3,817|
|2010-08-18||ANTH||Anthera Pharmaceuticals Inc||Buy||500||4.80||2,400|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hislop Colin (Chief Medical Officer of Versartis, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.